在社区获得的肺炎 (CAP5) 中进行5天的短期抗生素治疗:随机对照试验的研究协议
Simone Bastrup Israelsen1, Sandra Tingsgård2, Louise Thorlacius-Ussing2
1Department of Infectious Diseases, Copenhagen University Hospital, Amager and Hvidovre, Hvidovre, Denmark simone.elisabeth.bastrup.israelsen.02@regionh.dk.
社区获得性肺炎 (CAP) 的短期抗生素治疗是有效和安全的. 这项试验验证了更短的治疗时间,旨在改善CAP患者的临床实践.
科学领域:
- 传染性疾病 传染性疾病
- 临床试验 临床试验
- 抗生素管理局 抗生素管理局
背景情况:
- 社区获得性肺炎 (CAP) 抗生素治疗的最佳持续时间仍然不确定.
- 短期抗生素治疗在临床试验中表现有希望,但缺乏广泛的临床采用.
- 需要验证CAP的更短的治疗策略,以指导临床实践.
研究的目的:
- 评估住院CAP患者短期抗生素治疗的疗效和安全性.
- 以临床稳定性为指导的评估短期抗生素治疗.
- 提供证据,证明在CAP管理中实施更短的抗生素持续时间.
主要方法:
- 一项随机对照试验,采用非劣势设计,涉及丹麦六家医院的564名患者.
- 参与者被随机分配到5天的短期抗生素治疗或至少7天的治疗.
- 主要结局:90天无再入院生存期;次要结局:包括不良事件和住院住院在内的安全措施.
主要成果:
- 该研究正在进行中,结果尚未公布.
- 该试验旨在证明短期治疗的非劣势性.
- 数据收集计划在2019年至2024年之间进行.
结论:
- 这项实用性试验将提供关键证据,证明CAP的短期抗生素治疗的有效性.
- 预计这些发现将为临床指导方针提供信息,并改善抗生素管理.
- 成功验证可能会导致减少抗生素的使用和改善患者的治疗结果.
更多相关视频
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
相关概念视频
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Acute Pyelonephritis II: Diagnostic Studies and Management
Atypical Pneumonia
Pneumonia I: Introduction
